Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | D128N | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E455Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E688D | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E74Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | F173F | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | G338E | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | K588N | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | L445L | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | V485V | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | V548L | Missense | 1 |
| BRCA | Breast invasive carcinoma | A491A | Silent | 1 |
| BRCA | Breast invasive carcinoma | G120D | Missense | 1 |
| BRCA | Breast invasive carcinoma | H278D | Missense | 1 |
| BRCA | Breast invasive carcinoma | H39Q | Missense | 1 |
| BRCA | Breast invasive carcinoma | S234S | Silent | 1 |
| CESC | Cervical and endocervical cancers | A475V | Missense | 1 |
| CESC | Cervical and endocervical cancers | L337V | Missense | 1 |
| CESC | Cervical and endocervical cancers | L445L | Silent | 1 |
| CESC | Cervical and endocervical cancers | M788I | Missense | 1 |
| COAD | Colon adenocarcinoma | G292R | Missense | 1 |
| COAD | Colon adenocarcinoma | G776R | Missense | 1 |
| COAD | Colon adenocarcinoma | P277P | Silent | 1 |
| COAD | Colon adenocarcinoma | Q24H | Missense | 1 |
| COAD | Colon adenocarcinoma | R558W | Missense | 1 |
| COAD | Colon adenocarcinoma | V248I | Missense | 1 |
| ESCA | Esophageal carcinoma | G411R | Missense | 1 |
| ESCA | Esophageal carcinoma | H135L | Missense | 1 |
| ESCA | Esophageal carcinoma | I467T | Missense | 1 |
| ESCA | Esophageal carcinoma | S234S | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | E200E | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | E383K | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | E438G | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | Q133Q | Silent | 1 |
| KIRP | Kidney renal papillary cell carcinoma | R634R | Silent | 1 |
| LGG | Brain Lower Grade Glioma | C412C | Silent | 1 |
| LGG | Brain Lower Grade Glioma | E81* | Nonsense | 1 |
| LGG | Brain Lower Grade Glioma | T21M | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | V447F | Missense | 1 |
| LUAD | Lung adenocarcinoma | D780H | Missense | 1 |
| LUAD | Lung adenocarcinoma | S737G | Missense | 1 |
| LUAD | Lung adenocarcinoma | V248I | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | P241H | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | S643S | Silent | 1 |
| PAAD | Pancreatic adenocarcinoma | H695H | Silent | 1 |
| PAAD | Pancreatic adenocarcinoma | R364H | Missense | 1 |
| PCPG | Pheochromocytoma and Paraganglioma | S737S | Silent | 1 |
| SARC | Sarcoma | A178A | Silent | 1 |
| SARC | Sarcoma | R732R | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | A748A | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | C238S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | Q80* | Nonsense | 1 |
| SKCM | Skin Cutaneous Melanoma | R494G | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | R732C | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | S549F | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | V363G | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | V738V | Silent | 1 |
| STAD | Stomach adenocarcinoma | A231V | Missense | 1 |
| STAD | Stomach adenocarcinoma | A583A | Silent | 1 |
| STAD | Stomach adenocarcinoma | C597C | Silent | 1 |
| STAD | Stomach adenocarcinoma | G741G | Silent | 1 |
| STAD | Stomach adenocarcinoma | K144M | Missense | 1 |
| STAD | Stomach adenocarcinoma | K789E | Missense | 1 |
| STAD | Stomach adenocarcinoma | S229Y | Missense | 1 |
| STAD | Stomach adenocarcinoma | S725S | Silent | 1 |
| STAD | Stomach adenocarcinoma | T343T | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | D484G | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R148C | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R526H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R707W | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S113L | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | V425V | Silent | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 12 | 15.9 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 8 | 6.8 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 4 | 6.8 | 0 |
| COAD | Colon adenocarcinoma | 367 | 4 | 11.4 | 0 |
| ESCA | Esophageal carcinoma | 185 | 4 | 6.8 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 8 | 4.5 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 4 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 4 | 2.3 | 50 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 2.3 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 0 | 6.8 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 4 | 2.3 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 4 | 2.3 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 4 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 8 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 8 | 11.4 | 50 |
| STAD | Stomach adenocarcinoma | 393 | 20 | 9.1 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 4 | 11.4 | 0 |